Ocular Therapeutix
OCUL
OCUL
141 hedge funds and large institutions have $445M invested in Ocular Therapeutix in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 49 increasing their positions, 48 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
5.24% less ownership
Funds ownership: 63.39% → 58.16% (-5.2%)
27% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 22
35% less capital invested
Capital invested by funds: $685M → $445M (-$239M)
Holders
141
Holding in Top 10
5
Calls
$19M
Puts
$9.56M
Top Buyers
| 1 | +$5M | |
| 2 | +$4.32M | |
| 3 | +$3M | |
| 4 |
Millennium Management
New York
|
+$2.66M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$1.82M |
Top Sellers
| 1 | -$18M | |
| 2 | -$13M | |
| 3 | -$9.43M | |
| 4 |
AS
Altshuler Shaham
Tel Aviv,
Israel
|
-$4.33M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$3.74M |